Global Hereditary Angioedema Drug Market Research Report 2026(Status and Outlook)
In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Hereditary Angioedema Drug market size was estimated at USD 819.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Angioedema Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Angioedema Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Angioedema Drug market.
Global Hereditary Angioedema Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Market Segmentation (by Type)
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market Segmentation (by Application)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Drug Market
Overview of the regional outlook of the Hereditary Angioedema Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hereditary Angioedema Drug market size was estimated at USD 819.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Angioedema Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Angioedema Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Angioedema Drug market.
Global Hereditary Angioedema Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Market Segmentation (by Type)
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market Segmentation (by Application)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Drug Market
Overview of the regional outlook of the Hereditary Angioedema Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Drug
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Drug Segment by Type
1.2.2 Hereditary Angioedema Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Angioedema Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Drug Product Life Cycle
3.3 Global Hereditary Angioedema Drug Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Angioedema Drug Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Angioedema Drug Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Drug Market Size by Type (2020-2025)
6.4 Global Hereditary Angioedema Drug Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Drug Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA DRUG MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Drug Sales by Region
8.1.1 Global Hereditary Angioedema Drug Sales by Region
8.1.2 Global Hereditary Angioedema Drug Sales Market Share by Region
8.2 Global Hereditary Angioedema Drug Market Size by Region
8.2.1 Global Hereditary Angioedema Drug Market Size by Region
8.2.2 Global Hereditary Angioedema Drug Market Size by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Drug Sales by Country
8.3.2 North America Hereditary Angioedema Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Drug Sales by Country
8.4.2 Europe Hereditary Angioedema Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Drug Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Drug Sales by Country
8.6.2 South America Hereditary Angioedema Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Drug Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Drug by Region(2020-2025)
9.2 Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Drug Production
9.4.1 North America Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Drug Production
9.5.1 Europe Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Drug Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Drug Production (2020-2025)
9.7.1 China Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pharming Group NV
10.1.1 Pharming Group NV Basic Information
10.1.2 Pharming Group NV Hereditary Angioedema Drug Product Overview
10.1.3 Pharming Group NV Hereditary Angioedema Drug Product Market Performance
10.1.4 Pharming Group NV Business Overview
10.1.5 Pharming Group NV SWOT Analysis
10.1.6 Pharming Group NV Recent Developments
10.2 Takeda
10.2.1 Takeda Basic Information
10.2.2 Takeda Hereditary Angioedema Drug Product Overview
10.2.3 Takeda Hereditary Angioedema Drug Product Market Performance
10.2.4 Takeda Business Overview
10.2.5 Takeda SWOT Analysis
10.2.6 Takeda Recent Developments
10.3 CSL Limited
10.3.1 CSL Limited Basic Information
10.3.2 CSL Limited Hereditary Angioedema Drug Product Overview
10.3.3 CSL Limited Hereditary Angioedema Drug Product Market Performance
10.3.4 CSL Limited Business Overview
10.3.5 CSL Limited SWOT Analysis
10.3.6 CSL Limited Recent Developments
10.4 IBio Inc.
10.4.1 IBio Inc. Basic Information
10.4.2 IBio Inc. Hereditary Angioedema Drug Product Overview
10.4.3 IBio Inc. Hereditary Angioedema Drug Product Market Performance
10.4.4 IBio Inc. Business Overview
10.4.5 IBio Inc. Recent Developments
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 BioCryst Pharmaceuticals, Inc. Basic Information
10.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
10.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Market Performance
10.5.4 BioCryst Pharmaceuticals, Inc. Business Overview
10.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Ionis Pharmaceuticals, Inc. Basic Information
10.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
10.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Market Performance
10.6.4 Ionis Pharmaceuticals, Inc. Business Overview
10.6.5 Ionis Pharmaceuticals, Inc. Recent Developments
11 HEREDITARY ANGIOEDEMA DRUG MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Drug Market Size Forecast
11.2 Global Hereditary Angioedema Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Drug Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Angioedema Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Drug by Type (2026-2035)
12.1.2 Global Hereditary Angioedema Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Angioedema Drug by Type (2026-2035)
12.2 Global Hereditary Angioedema Drug Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Drug
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Drug Segment by Type
1.2.2 Hereditary Angioedema Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Angioedema Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Drug Product Life Cycle
3.3 Global Hereditary Angioedema Drug Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Angioedema Drug Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Angioedema Drug Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Drug Market Size by Type (2020-2025)
6.4 Global Hereditary Angioedema Drug Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Drug Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA DRUG MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Drug Sales by Region
8.1.1 Global Hereditary Angioedema Drug Sales by Region
8.1.2 Global Hereditary Angioedema Drug Sales Market Share by Region
8.2 Global Hereditary Angioedema Drug Market Size by Region
8.2.1 Global Hereditary Angioedema Drug Market Size by Region
8.2.2 Global Hereditary Angioedema Drug Market Size by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Drug Sales by Country
8.3.2 North America Hereditary Angioedema Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Drug Sales by Country
8.4.2 Europe Hereditary Angioedema Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Drug Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Drug Sales by Country
8.6.2 South America Hereditary Angioedema Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Drug Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Drug by Region(2020-2025)
9.2 Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Drug Production
9.4.1 North America Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Drug Production
9.5.1 Europe Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Drug Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Drug Production (2020-2025)
9.7.1 China Hereditary Angioedema Drug Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pharming Group NV
10.1.1 Pharming Group NV Basic Information
10.1.2 Pharming Group NV Hereditary Angioedema Drug Product Overview
10.1.3 Pharming Group NV Hereditary Angioedema Drug Product Market Performance
10.1.4 Pharming Group NV Business Overview
10.1.5 Pharming Group NV SWOT Analysis
10.1.6 Pharming Group NV Recent Developments
10.2 Takeda
10.2.1 Takeda Basic Information
10.2.2 Takeda Hereditary Angioedema Drug Product Overview
10.2.3 Takeda Hereditary Angioedema Drug Product Market Performance
10.2.4 Takeda Business Overview
10.2.5 Takeda SWOT Analysis
10.2.6 Takeda Recent Developments
10.3 CSL Limited
10.3.1 CSL Limited Basic Information
10.3.2 CSL Limited Hereditary Angioedema Drug Product Overview
10.3.3 CSL Limited Hereditary Angioedema Drug Product Market Performance
10.3.4 CSL Limited Business Overview
10.3.5 CSL Limited SWOT Analysis
10.3.6 CSL Limited Recent Developments
10.4 IBio Inc.
10.4.1 IBio Inc. Basic Information
10.4.2 IBio Inc. Hereditary Angioedema Drug Product Overview
10.4.3 IBio Inc. Hereditary Angioedema Drug Product Market Performance
10.4.4 IBio Inc. Business Overview
10.4.5 IBio Inc. Recent Developments
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 BioCryst Pharmaceuticals, Inc. Basic Information
10.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
10.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Market Performance
10.5.4 BioCryst Pharmaceuticals, Inc. Business Overview
10.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Ionis Pharmaceuticals, Inc. Basic Information
10.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
10.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Market Performance
10.6.4 Ionis Pharmaceuticals, Inc. Business Overview
10.6.5 Ionis Pharmaceuticals, Inc. Recent Developments
11 HEREDITARY ANGIOEDEMA DRUG MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Drug Market Size Forecast
11.2 Global Hereditary Angioedema Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Drug Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Angioedema Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Drug by Type (2026-2035)
12.1.2 Global Hereditary Angioedema Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Angioedema Drug by Type (2026-2035)
12.2 Global Hereditary Angioedema Drug Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Drug Market Size by Application
Table 5. Hereditary Angioedema Drug Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2025)
Table 11. Global Market Hereditary Angioedema Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Angioedema Drug Sales by Type (K MT)
Table 27. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 28. Global Hereditary Angioedema Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Drug Market Share by Type (2020-2025)
Table 32. Global Hereditary Angioedema Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Hereditary Angioedema Drug Sales (K MT) by Application
Table 34. Global Hereditary Angioedema Drug Market Size by Application
Table 35. Global Hereditary Angioedema Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Angioedema Drug Market Share by Application (2020-2025)
Table 39. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Angioedema Drug Market Size by Region (2020-2025)
Table 44. North America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Angioedema Drug Production (K MT) by Region(2020-2025)
Table 55. Global Hereditary Angioedema Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pharming Group NV Basic Information
Table 63. Pharming Group NV Hereditary Angioedema Drug Product Overview
Table 64. Pharming Group NV Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pharming Group NV Business Overview
Table 66. Pharming Group NV SWOT Analysis
Table 67. Pharming Group NV Recent Developments
Table 68. Takeda Basic Information
Table 69. Takeda Hereditary Angioedema Drug Product Overview
Table 70. Takeda Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Takeda Business Overview
Table 72. Takeda SWOT Analysis
Table 73. Takeda Recent Developments
Table 74. CSL Limited Basic Information
Table 75. CSL Limited Hereditary Angioedema Drug Product Overview
Table 76. CSL Limited Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. CSL Limited Business Overview
Table 78. CSL Limited SWOT Analysis
Table 79. CSL Limited Recent Developments
Table 80. IBio Inc. Basic Information
Table 81. IBio Inc. Hereditary Angioedema Drug Product Overview
Table 82. IBio Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. IBio Inc. Business Overview
Table 84. IBio Inc. Recent Developments
Table 85. BioCryst Pharmaceuticals, Inc. Basic Information
Table 86. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
Table 87. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioCryst Pharmaceuticals, Inc. Business Overview
Table 89. BioCryst Pharmaceuticals, Inc. Recent Developments
Table 90. Ionis Pharmaceuticals, Inc. Basic Information
Table 91. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
Table 92. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ionis Pharmaceuticals, Inc. Business Overview
Table 94. Ionis Pharmaceuticals, Inc. Recent Developments
Table 95. Global Hereditary Angioedema Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Hereditary Angioedema Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Hereditary Angioedema Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Hereditary Angioedema Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Hereditary Angioedema Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Hereditary Angioedema Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Hereditary Angioedema Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Drug Market Size by Application
Table 5. Hereditary Angioedema Drug Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2025)
Table 11. Global Market Hereditary Angioedema Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Angioedema Drug Sales by Type (K MT)
Table 27. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 28. Global Hereditary Angioedema Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Drug Market Share by Type (2020-2025)
Table 32. Global Hereditary Angioedema Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Hereditary Angioedema Drug Sales (K MT) by Application
Table 34. Global Hereditary Angioedema Drug Market Size by Application
Table 35. Global Hereditary Angioedema Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Angioedema Drug Market Share by Application (2020-2025)
Table 39. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Angioedema Drug Market Size by Region (2020-2025)
Table 44. North America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Angioedema Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hereditary Angioedema Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Angioedema Drug Production (K MT) by Region(2020-2025)
Table 55. Global Hereditary Angioedema Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pharming Group NV Basic Information
Table 63. Pharming Group NV Hereditary Angioedema Drug Product Overview
Table 64. Pharming Group NV Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pharming Group NV Business Overview
Table 66. Pharming Group NV SWOT Analysis
Table 67. Pharming Group NV Recent Developments
Table 68. Takeda Basic Information
Table 69. Takeda Hereditary Angioedema Drug Product Overview
Table 70. Takeda Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Takeda Business Overview
Table 72. Takeda SWOT Analysis
Table 73. Takeda Recent Developments
Table 74. CSL Limited Basic Information
Table 75. CSL Limited Hereditary Angioedema Drug Product Overview
Table 76. CSL Limited Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. CSL Limited Business Overview
Table 78. CSL Limited SWOT Analysis
Table 79. CSL Limited Recent Developments
Table 80. IBio Inc. Basic Information
Table 81. IBio Inc. Hereditary Angioedema Drug Product Overview
Table 82. IBio Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. IBio Inc. Business Overview
Table 84. IBio Inc. Recent Developments
Table 85. BioCryst Pharmaceuticals, Inc. Basic Information
Table 86. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
Table 87. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioCryst Pharmaceuticals, Inc. Business Overview
Table 89. BioCryst Pharmaceuticals, Inc. Recent Developments
Table 90. Ionis Pharmaceuticals, Inc. Basic Information
Table 91. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Overview
Table 92. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ionis Pharmaceuticals, Inc. Business Overview
Table 94. Ionis Pharmaceuticals, Inc. Recent Developments
Table 95. Global Hereditary Angioedema Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Hereditary Angioedema Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Hereditary Angioedema Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Hereditary Angioedema Drug Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Hereditary Angioedema Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Hereditary Angioedema Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Hereditary Angioedema Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Hereditary Angioedema Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Hereditary Angioedema Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Drug Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Angioedema Drug Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Angioedema Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Drug Product Life Cycle
Figure 13. Hereditary Angioedema Drug Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Angioedema Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Drug Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Angioedema Drug
Figure 19. Global Hereditary Angioedema Drug Market PEST Analysis
Figure 20. Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Drug Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Drug by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Drug by Type in 2025
Figure 29. Market Share of Hereditary Angioedema Drug by Type (2020-2025)
Figure 30. Market Share of Hereditary Angioedema Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Drug Market Share by Application
Figure 33. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Drug Sales Market Share by Application in 2025
Figure 35. Global Hereditary Angioedema Drug Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Drug Market Share by Application in 2025
Figure 37. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Drug Market Size by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Drug Market Size by Country in 2024
Figure 45. U.S. Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Drug Market Size by Country in 2024
Figure 55. Germany Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Drug Market Size by Region in 2024
Figure 68. China Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Drug Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Drug Market Size by Country in 2024
Figure 82. Brazil Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Drug Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hereditary Angioedema Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Angioedema Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Angioedema Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Angioedema Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Angioedema Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Drug Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Angioedema Drug Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Angioedema Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Drug Product Life Cycle
Figure 13. Hereditary Angioedema Drug Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Angioedema Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Drug Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Angioedema Drug
Figure 19. Global Hereditary Angioedema Drug Market PEST Analysis
Figure 20. Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Drug Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Drug by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Drug by Type in 2025
Figure 29. Market Share of Hereditary Angioedema Drug by Type (2020-2025)
Figure 30. Market Share of Hereditary Angioedema Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Drug Market Share by Application
Figure 33. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Drug Sales Market Share by Application in 2025
Figure 35. Global Hereditary Angioedema Drug Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Drug Market Share by Application in 2025
Figure 37. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Drug Market Size by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Drug Market Size by Country in 2024
Figure 45. U.S. Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Drug Market Size by Country in 2024
Figure 55. Germany Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Drug Market Size by Region in 2024
Figure 68. China Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Drug Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Drug Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Drug Market Size by Country in 2024
Figure 82. Brazil Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Drug Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hereditary Angioedema Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Angioedema Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Angioedema Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Angioedema Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Angioedema Drug Market Share Forecast by Application (2026-2035)
